×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
中科院强磁场科学中心 [1]
合肥创新院 [1]
中科院等离子体物理研... [1]
中科院安徽光学精密机... [1]
作者
李红 [1]
陈军 [1]
龚平 [1]
杨西 [1]
周跃 [1]
王化 [1]
更多...
发表日期
2022 [6]
2021 [5]
2020 [4]
2019 [2]
2018 [2]
2017 [2]
更多...
语种
英语 [22]
中文 [2]
出处
CHINESE ME... [5]
中国肿瘤生物治疗杂志 [2]
ACTA PHARM... [1]
ADVANCED H... [1]
ANNALS OF ... [1]
BOSNIAN JO... [1]
更多...
资助项目
100-Talent... [1]
Basic Disc... [1]
Basic Publ... [1]
Cancer Res... [1]
Cancer Res... [1]
Cancer Res... [1]
更多...
资助机构
National N... [4]
Natural Sc... [2]
Xisike-Han... [2]
Zhejiang C... [2]
100-Talent... [1]
Basic Disc... [1]
更多...
收录类别
SCI [16]
CSCD [9]
摘要
文献类型
期刊论文 [25]
学位论文 [2]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共27条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
WOS被引频次升序
WOS被引频次降序
期刊影响因子升序
期刊影响因子降序
作者升序
作者降序
A prospective, open-label, multicenter phase IV clinical trial on the safety and efficacy of lobaplatin-based chemotherapy in advanced breast cancer
期刊论文
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 卷号: 14
作者:
Yan, Min
;
Yuan, Peng
;
Ouyang, Quchang
;
Cheng, Ying
;
Han, Guohui
;
Wang, Dewei
;
Ran, Li
;
Sun, Tao
;
Zhao, Da
;
Bai, Yuju
;
Yang, Shun'e
;
Wang, Xiaojia
;
Wu, Rong
;
Zeng, Xiaohua
;
Yao, Herui
;
Ji, Xuening
;
Jiang, Jun
;
Hu, Xiaohua
;
Lin, Haifeng
;
Zheng, Liping
;
Zhu, Zhitu
;
Ge, Wei
;
Yang, Junlan
;
Cui, Tongjian
;
Zhang, Xiaozhi
;
Lu, Fangyang
;
Li, Wenhui
;
Xu, Hongyan
;
Kang, Mafei
;
Gong, Ping
;
Zou, Liqun
;
Liu, Jiang
;
Zhang, Hongliang
;
Yu, Hao
;
Xu, Binghe
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2022/12/23
breast cancer
chemotherapy
efficacy
lobaplatin
neoplasm metastasis
safety
Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis
期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11
作者:
Lei, Lei
;
Chen, Rucheng
;
Fan, Lei
;
Zheng, Weijun
;
Wang, Xiaojia
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/12/23
Breast cancer
nanoparticle-albumin-bound paclitaxel (Nab-P)
taxanes
meta-analysis
Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study
期刊论文
GENES CHROMOSOMES & CANCER, 2022
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Si, Jinfei
;
Pu, Xingxiang
;
Wang, Liping
;
Chen, Huafei
;
Xu, Chunwei
;
Zhang, Xiaoyan
;
Yuan, Hongling
;
Lou, Guangyuan
;
Shao, Lan
;
Zhang, Gu
;
Song, Zhengbo
收藏
  |  
浏览/下载:55/0
  |  
提交时间:2022/05/16
BRAF mutation
immune checkpoint inhibitors
non-small cell lung cancer
PD-L1
targeted therapy
Neoadjuvant Therapy for Locally Advanced or Oligometastatic Prostate Cancer: a Retrospective Comparative Single-Center Study
期刊论文
INDIAN JOURNAL OF SURGERY, 2022
作者:
Wang, Qibo
;
Xu, Yipeng
;
Zeng, Xiaowei
;
Chen, Jinchao
;
He, Yedie
;
Wang, Zongping
;
Wang, Hua
;
Zhu, Shaoxing
;
Li, Fangyin
收藏
  |  
浏览/下载:52/0
  |  
提交时间:2022/05/16
Prostate cancer
Neoadjuvant chemohormonal therapy
Neoadjuvant hormonal therapy
Prostatectomy
Surgical outcomes
Evaluation of JQ1 Combined With Docetaxel for the Treatment of Prostate Cancer Cells in 2D-and 3D-Culture Systems
期刊论文
FRONTIERS IN PHARMACOLOGY, 2022, 卷号: 13
作者:
Xu, Yipeng
;
Pachnikova, Gabriela
;
Przybilla, Dorothea
;
Schafer, Reinhold
;
Cui, Yingying
;
Zhou, Dan
;
Chen, Zihao
;
Zhao, An
;
Keilholz, Ulrich
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2022/03/28
Prostate Cancer
JQ1
Docetaxel
Combination Treatment
3D Culture Spheroid
IC50: an unsuitable measure for large-sized prostate cancer spheroids in drug sensitivity evaluation
期刊论文
BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2022, 卷号: 22
作者:
Xu, Yipeng
;
Pachnikova, Gabriela
;
Wang, He
;
Wu, Yaoyao
;
Przybilla, Dorothea
;
Schaefer, Reinhold
;
Chen, Zihao
;
Zhu, Shaoxing
;
Keilholz, Ulrich
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2022/12/23
IC50
docetaxel
spheroids
drug testing
preclinical models
prostate cancer
2D clinical models
3D clinical models
cell culture
The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study
期刊论文
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2021
作者:
Wang, Wenxian
;
Gu, Xiaodong
;
Wang, Liping
;
Pu, Xingxiang
;
Feng, Huijing
;
Xu, Chunwei
;
Lou, Guangyuan
;
Shao, Lan
;
Xu, Yibing
;
Wang, Qian
;
Wang, Siyuan
;
Gao, Wenbin
;
Zhang, Yiping
;
Song, Zhengbo
收藏
  |  
浏览/下载:67/0
  |  
提交时间:2022/01/10
Non-small cell lung cancer
PD-L1
Immune checkpoint inhibitor
Immune-related adverse event
Impact of cumulative cisplatin dose in childhood nasopharyngeal carcinoma based on neoadjuvant chemotherapy response in the intensity-modulated radiotherapy era: a real-world study
期刊论文
CANCER CELL INTERNATIONAL, 2021, 卷号: 21
作者:
Jin, Ya-Nan
;
Qiang, Meng-Yun
;
Liu, Meng-Meng
;
Cheng, Zhi-Bin
;
Zhang, Wang-Jian
;
Ryan, Ian
;
Marks, Tia
;
Yao, Ji-Jin
;
Xia, Liang-Ping
收藏
  |  
浏览/下载:57/0
  |  
提交时间:2022/01/10
Nasopharyngeal carcinoma
Cumulative cisplatin dose
Children and adolescents
Tumor response
Neoadjuvant chemotherapy
Anlotinib plus docetaxel versus docetaxel as second-line treatment for advanced non-small cell lung cancer (NSCLC): Updated results from a phase I/II study.
期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:
Fang, Yong
;
Pan, Hongming
;
Shou, Jiawei
;
Hong, Wei
;
Guo, Qunyi
;
Yang, Xinmei
;
Zhu, Dan
;
Chen, Jun
;
Lu, Liqin
;
Rao, Chuangzhou
;
Lan, Fen
收藏
  |  
浏览/下载:36/0
  |  
提交时间:2022/01/10
Anlotinib plus Docetaxel versus Docetaxel as 2nd Line Treatment in Advanced Non-Small Cell Lung Cancer: A Phase I/II Study
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2021, 卷号: 16
作者:
Fang, Y.
;
Pan, H.
;
Shou, J.
;
Hong, W.
;
Yang, X.
;
Zhu, D.
;
Zhou, Y.
;
Lan, F.
;
Rao, C.
;
Chen, J.
收藏
  |  
浏览/下载:51/0
  |  
提交时间:2021/05/17
Anlotinib
NSCLC
anti-angiogenesis